This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 Oct;151(10):1144.

doi: 10.1001/jamadermatol.2015.1683.

In Reply

Kyle M Coleman¹, Johann E Gudjonsson², Michael Stecher³

Affiliations

Affiliations

¹ Westlake Dermatology and Cosmetic Surgery, Austin, Texas.
² Department of Dermatology, University of Michigan, Ann Arbor, Michigan.
³ XBiotech USA Inc, Austin, Texas.

PMID: 26465767
DOI: 10.1001/jamadermatol.2015.1683

Comment

In Reply

Kyle M Coleman et al. JAMA Dermatol. 2015 Oct.

. 2015 Oct;151(10):1144.

doi: 10.1001/jamadermatol.2015.1683.

Authors

Kyle M Coleman¹, Johann E Gudjonsson², Michael Stecher³

Affiliations

¹ Westlake Dermatology and Cosmetic Surgery, Austin, Texas.
² Department of Dermatology, University of Michigan, Ann Arbor, Michigan.
³ XBiotech USA Inc, Austin, Texas.

PMID: 26465767
DOI: 10.1001/jamadermatol.2015.1683

No abstract available

PubMed Disclaimer

Comment on

Open-Label Trial of MABp1, a True Human Monoclonal Antibody Targeting Interleukin 1α, for the Treatment of Psoriasis.
Coleman KM, Gudjonsson JE, Stecher M. Coleman KM, et al. JAMA Dermatol. 2015 May;151(5):555-6. doi: 10.1001/jamadermatol.2014.5391. JAMA Dermatol. 2015. PMID: 25715176 Clinical Trial. No abstract available.
Reporting of MABp1 for the Treatment of Psoriasis.
Mansouri B, Menter A. Mansouri B, et al. JAMA Dermatol. 2015 Oct;151(10):1143-4. doi: 10.1001/jamadermatol.2015.1684. JAMA Dermatol. 2015. PMID: 26465764 No abstract available.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information